Reportedly, the experimental conditions closely mimic ischemia, including the depletion of ATP evidenced by immediate adenosine receptor-dependent decreases in neurotransmitter release efficiency [9, 45, 46] and activation of microglial complement receptor 3 (CR3) [8]. The gene discussed is CRIPTO3; the disease is ischemia.